Last reviewed · How we verify
NCT05652023: NUADD
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
trial in Bladder Dysfunction in 2,023 participants. Currently enrolling.
20 December 2027
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,023 |
| Start date | 20 April 2023 |
| Primary completion | 20 December 2027 |
| Estimated completion | 20 December 2028 |
| Sites | 1 location across United States |
Conditions studied
- Bladder Dysfunction — all drugs for Bladder Dysfunction →
- Overactive Bladder — all drugs for Overactive Bladder →
- BPH With Urinary Obstruction — all drugs for BPH With Urinary Obstruction →
Sponsor
Mayo Clinic
Who can join
Adults 18 to 90, any sex, with Bladder Dysfunction or Overactive Bladder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05652023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bladder Dysfunction
Currently open trials in the same condition.
- NCT07355803 — Define Final Selection Choice Criteria for a Coloplast Catheter Ensuring Highest Patient Satisfaction Via Surveys (EVA). · NA · recruiting
- NCT07019597 — NESA Neuromodulation Versus Transcutaneous Posterior Tibial Stimulation · NA · recruiting
- NCT06472193 — The Utility of Shanfield Implantation Technique During Creation of Mitrofanoff Procedure in Pediatric Age Group · NA · recruiting
- NCT05462561 — Vascularized Composite Bladder Allograft Transplantation · NA · recruiting
- NCT04993859 — Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05652023 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05652023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing